SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,048 | -50.3% | 39,936 | 0.0% | 0.00% | – |
| Q2 2023 | $191,293 | +17.9% | 39,936 | +39.5% | 0.00% | – |
| Q1 2023 | $162,315 | +1.3% | 28,627 | 0.0% | 0.00% | – |
| Q4 2022 | $160,311 | -20.3% | 28,627 | -8.6% | 0.00% | – |
| Q3 2022 | $201,036 | +80.4% | 31,314 | -3.6% | 0.00% | – |
| Q2 2022 | $111,448 | -47.8% | 32,492 | +8.4% | 0.00% | – |
| Q1 2022 | $213,429 | -30.7% | 29,976 | -19.0% | 0.00% | – |
| Q4 2021 | $308,000 | +16.7% | 37,022 | -2.5% | 0.00% | – |
| Q3 2021 | $264,000 | -71.9% | 37,973 | -3.8% | 0.00% | -100.0% |
| Q2 2021 | $941,000 | +45.2% | 39,458 | +25.3% | 0.00% | 0.0% |
| Q1 2021 | $648,000 | -20.5% | 31,479 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $815,000 | -6.0% | 33,284 | +8.7% | 0.00% | 0.0% |
| Q3 2020 | $867,000 | +561.8% | 30,610 | +8.7% | 0.00% | – |
| Q2 2020 | $131,000 | +36.5% | 28,158 | +4.6% | 0.00% | – |
| Q1 2020 | $96,000 | +10.3% | 26,925 | +7.2% | 0.00% | – |
| Q4 2019 | $87,000 | -7.4% | 25,123 | +5.0% | 0.00% | – |
| Q3 2019 | $94,000 | -45.0% | 23,921 | +19.9% | 0.00% | – |
| Q2 2018 | $171,000 | +31.5% | 19,943 | +11.7% | 0.00% | – |
| Q1 2018 | $130,000 | -27.0% | 17,849 | +1.0% | 0.00% | – |
| Q4 2017 | $178,000 | -34.8% | 17,679 | +3.7% | 0.00% | – |
| Q3 2017 | $273,000 | +32.5% | 17,042 | -6.7% | 0.00% | – |
| Q2 2017 | $206,000 | +15.7% | 18,270 | +15.2% | 0.00% | – |
| Q1 2017 | $178,000 | +27.1% | 15,860 | +11.5% | 0.00% | – |
| Q4 2016 | $140,000 | -18.1% | 14,220 | +2.1% | 0.00% | – |
| Q3 2016 | $171,000 | -55.1% | 13,921 | +6.2% | 0.00% | -100.0% |
| Q2 2016 | $381,000 | +136.6% | 13,103 | +104.7% | 0.00% | – |
| Q1 2016 | $161,000 | +172.9% | 6,400 | +280.7% | 0.00% | – |
| Q4 2015 | $59,000 | +1080.0% | 1,681 | +849.7% | 0.00% | – |
| Q3 2015 | $5,000 | – | 177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |